
Don’t hit the panic button
On October 7, 2015, the High Court of Australia (the country’s most senior court) unanimously ruled that isolated naturally-occurring nucleic acids are not patentable subject matter. This decision overturned the earlier ruling of the Federal Court of Australia and the unanimous decision of the full Federal Court. The case results from a legal challenge to Myriad’s Australian patent number 686004 from breast cancer survivor Yvonne D’Arcy.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
